PMID: 38381Sep 1, 1978

Biological autoxidation. I. Decontrolled iron: an ultimate carcinogen and toxicant: an hypothesis

Medical Hypotheses
S H Kon

Abstract

Ionic iron at physiological pH hydrolyzes into insoluble aggregates, which disperse on slight acidification. Uncontrolled ionic iron promotes autoxidation, which crosslinks biomolecules and produces destructive activated oxygen. Defenses against autoxidative crosslinking include: 1. ferritin, the macromolecular scavenger of iron; 2. metabolic turnover, which prevents irreversible crosslinking through early catabolic degradation and replacement; and 3. enzymatic deactivation of oxygen. I am proposing that the anticrosslinking defenses are defeated by transient actions of metabolic perturbations, toxicants, oxidants and "foreign bodies", which cause oxidative crosslinking of proteins and lipids into irreversible tissue imprint: indigestible bodies containing porous limited-access spaces (LASs). The pores exclude the macromolecular ferritin and the digestive and antiautoxidation enzymes but admit ionic iron which, sheltered from ferritin, accumulates into decontrolled-iron pathogen (DIP). DIP utilizes the energy of ambient pH fluctuations to erupt from the LAS, swamp the available ferritin, poison the surroundings, catalyze autoxidation and crosslink cell components into additional LAS carriers. With time and sufficient promotion ...Continue Reading

References

Aug 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·A B Novikoff
Jan 1, 1976·Annual Review of Biochemistry·A L Goldberg, A C St John
Jan 1, 1977·Bulletin of Environmental Contamination and Toxicology·J J DoyleH D Petersen
Nov 1, 1975·The Journal of Clinical Investigation·M L Salin, J M McCord
Oct 1, 1972·CRC Critical Reviews in Toxicology·W S Hartroft, E A Portal
Jul 1, 1973·Proceedings of the Society for Experimental Biology and Medicine·R GruenewaldL Forbes
Sep 27, 1969·Lancet·T L Dormandy
Mar 1, 1973·The Journal of Clinical Investigation·B M BabiorJ T Curnutte
Apr 1, 1973·Lipids·W R Bidlack, A L Tappel
Nov 1, 1974·Angewandte Chemie·H Sies
Feb 1, 1974·Food and Cosmetics Toxicology·K D Brunnemann, D Hoffmann
May 1, 1972·International Journal of Radiation Biology and Related Studies in Physics, Chemistry, and Medicine·H Schuessler, P Denkl
Jan 1, 1974·Annual Review of Biochemistry·A L Goldberg, J F Dice
Jan 1, 1973·Angewandte Chemie·R R Crichton
Mar 1, 1973·British Journal of Haematology·A Polliack, E A Rachmilewitz
May 1, 1973·Environmental Letters·R R Gadde, H A Laitinen
Jan 1, 1974·The Journal of Membrane Biology·I Imanaga
May 1, 1969·The Journal of Pathology·W G Spector, N Heesom
Apr 4, 1970·Nature·I MillmanB S Blumberg
Apr 15, 1971·Comparative Biochemistry and Physiology. B, Comparative Biochemistry·E Misaka, A L Tappel
Sep 1, 1972·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·A M LangerI J Selikoff
Sep 1, 1972·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·A M LangerF D Pooley
Dec 1, 1971·Journal of Ultrastructure Research·F A FischbachJ M Williams
Jan 1, 1966·Annual Review of Physiology·C De Duve, R Wattiaux
Apr 6, 1968·South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
Apr 8, 1968·JAMA : the Journal of the American Medical Association·I J SelikoffJ Churg
Apr 1, 1969·Environmental Research·S Speil, J P Leineweber
Feb 15, 1966·Experientia·R J Shamberger, G Rudolph
Nov 5, 1966·Nature·Y Kanno, W R Loewenstein
Oct 1, 1952·The Biochemical Journal·P ALEXANDERL F SMITH
Jul 1, 1954·The Biochemical Journal·P F HOLT, J E BOWCOTT
Jun 1, 1963·Journal of Ultrastructure Research·G T MATIOLI, R F BAKER
Apr 1, 1963·Annals of Internal Medicine·J H JANDL
Mar 1, 1964·Archives of Biochemistry and Biophysics·R H MCKAY, R A FINEBERG
Mar 1, 1964·Archives of Biochemistry and Biophysics·R H MCKAY, R A FINEBERG
Jan 1, 1960·Journal of Gerontology·R R KOHN, E ROLLERSON

Related Concepts

Asbestos
Tumor Promoters
Catalysis
Metal Antagonists
Hydrogen-Ion Concentration
Hydrolysis
Iron
Oxidation-Reduction

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.